Comparison of the Ability of Glulisine With Lispro to Control Type 1 Diabetes Mellitus in Children and Adolescents

NCT00115570 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

572

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Insulin-Dependent

Interventions

DRUG: Insulin glulisine
DRUG: insulin lispro
DRUG: insulin glargine
DRUG: NPH insulin

Sponsor

Sanofi